home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 02/28/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say | Benzinga

Viking Therapeutics Inc (NASDAQ:VKTX) recently released top-line results from a successful Phase 2 weight loss trial. Patients receiving VK2735 d...
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss | Benzinga

Eli Lilly And Co’s (NYSE:LLY) CEO, David Ricks, shared the pharmaceutical giant’s plans to introduce its obesity drug, tirzepatide...

Miracle Or Myth? Survey Shows Americans Doubt Ozempic, Wegovy's Weight Loss Claims | Benzinga

A recent study by the Pew Research Center has shown that a majority of Americans are doubtful about the potential of new weight loss drugs, such as...

EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows | Benzinga

Wednesday, Vivani Medical Inc (NASDAQ:VANI) released preclinical data on weight loss effects for NPM-115, the company’s miniature, ...
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs | Benzinga

Amgen Inc (NASDAQ:AMGN) is expected to unveil updates on various programs this year, targeting significant markets.  Despite concern...

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors | Benzinga

The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials ...

Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts | Benzinga

Goldman Sachs economists foresee a potential 1% boost to the United States’ Gross Domestic Product (GDP) in the coming years, attributin...
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand | Benzinga

While Novo Nordisk A/S (NYSE:NVO) faces challenges in meeting the global demand for its highly sought-after weight-loss treatment, Wegovy...

Weight-Loss Drugs Vs. Conagra Foods: Company Optimistic Amid Shifting Consumer Demands Influenced By Hunger Suppressing | Benzinga

At the Consumer Analyst Group of New York Conference in Boca Raton, Florida, Conagra Brands Inc (NYSE:CAG) Executive Tom McGough&nbs...

Ozempic Effect: Food Industry Feels The Heat As Weight-Loss Drugs Get Popular, Investors Call For Menu Makeovers | Benzinga

The rising popularity of weight-loss drugs like Ozempic is now pressuring food companies to reevaluate their business strategies. According to a re...
Previous 10 Next 10